CDKN2B and cancer: This situation contrasts with the emerging information related to the risk mechanisms at 9p21.3, where the function of one likely causal gene CDKN2B is associated with decreased risk for vascular disease [25], [50] as well as a broad range of human cancers [51]–[53].